eFFECTOR Therapeutics Stock

eFFECTOR Therapeutics P/B

P/B (Price-to-Book Ratio) of eFFECTOR Therapeutics (EFTR) as of Aug 16, 2026.

P/B

-0.00

YoY

-167.23%

Last updated:

P/B (Price-to-Book Ratio) of eFFECTOR Therapeutics is 2026 -0.00 . P/B (Price-to-Book Ratio) of eFFECTOR Therapeutics was 2025 0.00 . It decreases by -167.23% lower compared to the previous year.
Access this data via the Eulerpool API

eFFECTOR Therapeutics Stock analysis

What does eFFECTOR Therapeutics do? eFFECTOR Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about eFFECTOR Therapeutics stock

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) eFFECTOR Therapeutics since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s eFFECTOR Therapeutics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — eFFECTOR Therapeutics

All Key Metrics — eFFECTOR Therapeutics